Fast-food chain McDonald’s, an economic indicator because of its mammoth global presence, posted its worst earnings report since 2020.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
The Fed may have cracked inflation, but eggflation is proving harder to beat. Unsurprisingly, egg producer stocks are soaring.
After making itself an integral part of the supply chain for generative AI, Nvidia is eyeing other futuristic tech bets.
A day after antitrust enforcers successfully blocked Albertsons’ planned sale to Kroger, the former filed a lawsuit against the latter.
Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
The transaction would create the world’s largest advertising agency — that is, if you don’t count Big Tech players like Google and Amazon.
A federal appeals court upheld the “TikTok Ban” that would force China-based ByteDance to sell its app next month or face exile from the US.
The global oil cartel announced it would be extending its ongoing production cuts through the first few months of next year.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.
Shein and Temu have been able to keep the costs on their platforms alarmingly low, but there’s been a hidden political cost racking up.
SpaceX CEO Elon Musk will soon have a friend in very high places after Trump names Jared Isaacman to lead NASA.
Has CEO John Stankey, who took the position in 2020, effectively turned the corner on his turnaround plan at AT&T?
To prepare for a slowdown of global trade, US retailers spent months building a massive inventory to prevent empty shelves.
Hertz’s recent track record leaves much to be desired: the rental-car company lost nearly $2.9 billion last year.
Investor worries about a fresh batch of US tariffs have dragged LVMH shares in Paris down 23.6% so far this year.
The company plans to seek regulatory approval for the revolutionary weight loss treatment by the end of the year.